The 3D printing’s role in lifesaving development before and now.
Published on 10 Jun 2009 by Koen Van Roy. According to Dr. Gabor Forgacs,” made that prediction. Now, he is making it a reality. Gabor is a University of Missouri researcher doing groundbreaking work in regenerative medicine. He is also the Scientific Founder and Chief Scientific Officer of Organovo, the latest company to receive support from you, the donors of the Methuselah Foundation”.
According to the Euronews Knowledge,” it was published on 10 Jul 2013. Organ transplants have been a lifesaving development and one of the shining success stories of modern medicine. But the shortage of organs for transplantation is an ongoing problem. One answer is to grow them artificially in a laboratory – a promising although controversial solution.
The hope is to put human liver cells into that structure to see if they can grow and multiply into a fully functioning human liver.
Euronews knowledge brings you a fresh mix of the world’s most interesting know-hows, directly from Space and Sci-Tech experts”.
This is from the ‘Science Museum’s’ video, it was published on 8 Oct 2013. According to Materials scientist, Brian Derby,” thinks that it will be some time before working human organs can be 3D printed for transplant. But there are some surprising ways 3D printing can already heal you”.
Now— Artificial liver and transplantation by, SCOTT L. NYBERG.
According to some comments, and concerns, 1— Remon Michel 5 years ago we hope so much develop this solution.
2— Ayy Foo It’s Modelo Time 3 years ago Investing in this research.
3— zsdg15 6 years ago So in 2075 when I’m 80 I can replace most of my organs with a younger version of my organs to live to 110? 😀
4— group 6 years ago How do they regulate that the cells will divide? Like, do they only have cells in the bio-ink that are in S phase? How do they make the cells into mitosis?
5— Rebekkah Todd 6 years ago I strongly recommend that everyone invest in this company now while the stock is still low – also, SSYS, DDD, and ADSK – you are looking at the future….if you have any spare money to invest at all…
7— TheKingdomOfDragons 6 years ago OMG, that is SWEET 😀
8—Seeu anon 7 years ago We need to support this! I am unwell and need medical help.
9— Jordan Quenneville 7 years ago This blew my mind, but: This process would be fantastic if say, a healthy organ was suddenly damaged. But what if the organ failed for other reasons, like old age? What are the implications of using old cells? Would the new organ fail more quickly then? Also, if the organ failed because of a genetic disorder, wouldn’t the new one be just at risk of mutation and failure? In both these cases, what’s the longevity of these organs? What’s the longevity of an ideal printed organ?
10— djjmria 8 years ago I need a new right arm, do they also make those?
11— ProGameDev101 9 years ago Would Bio-engineering be the degree to get to help contribute to this type of technology?
12— booste30 9 years ago This guy’s going to win the Nobel Prize.
13— Strawbz7209 9 years ago This is one of the most amazing things I’ve ever seen.
14— Richard Monat 4 years ago Thank you for your time. I forgot to respond on time. 3-D printing is a footprint on the snow or sand, that real explorers will track. God, I’d love to see, even what’s the beginning. What a future from that TOOL. Richard.
I hope everybody from the comments section, find this post and read about the latest research:)
According to the Organovo,” This is a medical research company headquartered in San Diego which designs and develops three-dimensional human tissue. The living 3D printed tissue can be used for testing drugs before giving the drugs to a real person. Organovo uses a proprietary bioprinting platform called NovoGen for 3D printing tissue.
Pharmaceutical companies conventionally perform testing on animals or on cells in Petri-dishes. Both methods of testing are very different from testing on a living person. Therefore several clinical trials fail when tried on living person even if they were considered successful on animals or cells in petri-dish. Organovo technology bridges this gap by providing 3D tissue models that are much closer to a living person. Pharmaceutical companies can use the 3D tissues developed using this technology for testing.
In 2014 Organovo announced the commercial release of exVive3DTM Human Liver Tissue for preclinical drug discovery testing. In April 2015, Organovo presented results of 3D printing in vitro 3D kidney tissue at the 2015 Experimental Biology conference in Boston. In 2015 L’Oreal signed an agreement with Organovo to produce 3D printed skin for use in testing of cosmetics. The long-term goal of Organovo’s 3D bioprinting technology is to be able to create organs for transplantation”.:)
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.